North America Probiotics Market size was valued at USD 8,835.46 million in 2018 and increased to USD 14,495.79 million in 2024. It is anticipated to reach USD 28,622.51 million by 2032, growing at a CAGR of 9.0% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
North America Probiotics Market Size 2024
USD 14,495.79 million
North America Probiotics Market, CAGR
9.0%
North America Probiotics Market Size 2032
USD 28,622.51 million
The North America probiotics market is led by major players such as ADM, Nestle S.A., Danone S.A., Yakult Honsha Co., Ltd., Kerry Group, Lifeway Foods Inc., Lallemand Inc., Probi, Winclove Probiotics, SYNformulas, Hansen A/S, and International Flavors & Fragrances Inc. These companies drive growth through product innovation, clinical validation, and expansion into functional foods, dietary supplements, and animal feed. The United States dominates the regional market with over 75% share in 2024, supported by high consumer awareness, extensive product availability, and strong retail distribution networks. Canada and Mexico follow with 15% and 10% shares, respectively, reflecting rising demand for natural, functional, and preventive health solutions. Together, these dynamics highlight the competitive strength of leading firms and the geographic concentration of market growth.
Market Insights
The North America probiotics market was valued at USD 14,495.79 million in 2024 and is expected to reach USD 28,622.51 million by 2032, growing at a CAGR of 9.0%.
Rising consumer awareness of digestive and immune health, coupled with growing demand for functional foods and dietary supplements, is a key driver supporting market expansion.
Trends include increasing adoption of personalized nutrition, expansion of plant-based probiotic products, and integration of probiotics into animal feed as alternatives to antibiotics.
The market is highly competitive, with ADM, Nestle, Danone, Yakult, Kerry Group, and Lifeway Foods Inc. dominating, while companies like Lallemand Inc. and Probi focus on specialized probiotic strains and clinical validation.
Regionally, the United States leads with over 75% share, followed by Canada at 15% and Mexico at 10%; by product, probiotic food and beverages dominate with more than 70% share, reinforcing their strong consumer acceptance.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
In the North America probiotics market, probiotic food and beverages dominated in 2024 with over 70% share, led by dairy products such as yogurt and kefir. Strong consumer demand for functional foods, rising digestive health awareness, and the preference for natural solutions support this dominance. Dairy products remain widely accessible through retail channels and are supported by heavy marketing from global players. Probiotic dietary supplements also see steady growth, especially in capsules and infant formula, but food and beverages continue to lead due to higher consumption frequency and broader adoption.
For instance, Danone’s Activia line in North America contains ≥1×10⁷ CFU/g of Bifidobacterium animalis DN-173 010, supported by large-scale advertising campaigns across the U.S. and Canada.
By Ingredient
The bacteria segment held the dominant share in 2024, accounting for more than 85% of the market. Lactobacillus led this category, followed by Bifidobacterium, driven by clinical validation of their digestive and immune health benefits. Their widespread use in dairy, supplements, and fortified foods supports large-scale commercialization. Streptococcus and other strains play a smaller role in specialized products, while yeast, led by Saccharomyces boulardii, is growing in niche digestive applications. However, bacteria remain the core driver due to established safety records, consumer familiarity, and proven functional effectiveness.
For instance, Chr. Hansen supplies LGG® (Lactobacillus rhamnosus GG) standardized at 2×10¹¹ CFU/g, widely integrated into dairy and supplement formulations across North America.
By End User
Human probiotics dominated the market in 2024 with over 80% share, led by adult applications. Rising lifestyle-related digestive disorders, immune health concerns, and increasing adoption of preventive healthcare drive strong demand. Children’s probiotics are growing in popularity, particularly in infant formula and chewables, supported by parental focus on early gut health. Animal probiotics, including livestock, poultry, and aquaculture, are expanding steadily with growing demand for antibiotic-free animal feed. However, the human segment remains dominant as consumer awareness, clinical backing, and availability of diverse product forms reinforce its strong position.
Key Growth Drivers
Rising Consumer Awareness of Gut and Immune Health
awareness of the link between gut microbiota and overall health is a major growth driver for the North America probiotics market. Consumers are increasingly adopting probiotic-rich foods and supplements to manage digestive health issues, enhance immunity, and improve overall well-being. The shift toward preventive healthcare has boosted the demand for yogurt, kefir, and dietary supplements fortified with probiotic strains such as Lactobacillus and Bifidobacterium. Strong marketing campaigns by leading food and beverage companies have further educated consumers about probiotic benefits, encouraging higher adoption. This awareness is particularly evident in urban populations, where health-conscious individuals prefer natural, functional foods over synthetic alternatives. Rising cases of gastrointestinal disorders and lifestyle-related issues have also reinforced consumer reliance on probiotics. These factors continue to accelerate product penetration across mainstream retail channels, ensuring strong demand growth.
For instance, Danone’s Activia yogurt contains ≥1×10⁷ CFU/g of Bifidobacterium animalis DN-173 010, supporting digestive health benefits validated in clinical studies.
Expansion of Functional Foods and Beverages Segment
The rapid expansion of functional foods and beverages is driving strong market growth across North America. Dairy-based products, cereals, fermented meats, and baked goods are increasingly being fortified with probiotics, meeting consumer demand for convenient and health-oriented food options. The segment benefits from continuous product innovation, with manufacturers introducing flavored, plant-based, and low-sugar probiotic variants to appeal to diverse dietary preferences. For instance, the rise of vegan and lactose-intolerant consumers has led to the introduction of plant-based probiotic yogurts and beverages. Major food companies are investing in research to validate probiotic benefits, improving consumer confidence and expanding applications. Supermarkets and online platforms provide wide product availability, enhancing accessibility and visibility. With consumers seeking multifunctional foods that combine taste, nutrition, and convenience, the functional food and beverage category remains a primary driver of probiotic consumption. This segment continues to dominate the market due to frequent daily consumption patterns.
For instance, Chobani’s Probiotic Plant-Based Oat Drinks contain billions of probiotics, such as Lactobacillus and Bifidobacterium strains, in each serving, appealing to both plant-based and health-conscious consumers.
Advancements in Clinical Research and Strain Development
Advancements in probiotic strain research and clinical validation are key drivers accelerating the North American market. Scientific evidence supporting the role of probiotics in improving digestive health, reducing antibiotic-associated diarrhea, and enhancing immune function has reinforced consumer trust. Companies are increasingly investing in developing targeted strains for specific conditions, including allergies, obesity, and mental health, widening the potential applications. For example, specialized formulations for children and seniors are gaining traction, reflecting growing demand for personalized nutrition. The development of next-generation probiotics using biotechnology further enhances stability, shelf life, and effectiveness in diverse applications. Regulatory approvals and scientific endorsements from credible institutions also strengthen consumer adoption. With ongoing innovation, probiotic products are positioned as credible therapeutic and wellness solutions, supporting their transition from niche dietary aids to mainstream healthcare essentials. These advancements are expected to play a critical role in sustaining market growth.
Key Trends & Opportunities
Shift Toward Personalized Nutrition Solutions
Personalized nutrition is emerging as a key trend in the North America probiotics market. With consumers increasingly aware that individual gut microbiota varies widely, demand for customized probiotic solutions tailored to age, health condition, and lifestyle is rising. Companies are launching DNA-based microbiome tests that recommend specific probiotic strains suited to personal health needs. This approach aligns with the growing focus on precision healthcare and preventive medicine. For instance, targeted probiotics for conditions such as irritable bowel syndrome or lactose intolerance are gaining attention. Technology-enabled subscription models offering monthly probiotic packs tailored to personal requirements are also expanding. This shift presents strong opportunities for market players to differentiate offerings and build long-term consumer loyalty. Personalized nutrition not only elevates product credibility but also ensures sustained demand across diverse consumer groups, from children to the elderly, creating a major growth opportunity.
For instance, Seed Health introduced its DS-01® Daily Synbiotic, a 24-strain formulation delivering 53.6 billion AFU per dose, with strains selected to support digestive, immune, and dermatological health.
Integration of Probiotics in Animal Nutrition
The rising demand for sustainable and antibiotic-free animal feed is creating new opportunities for probiotics in livestock, poultry, and aquaculture. Farmers and producers are increasingly adopting probiotics to improve animal gut health, immunity, and growth performance while reducing reliance on antibiotics. Probiotic feed additives are gaining traction due to their ability to enhance feed efficiency, improve yield, and meet stringent food safety regulations. This trend is particularly strong in poultry production, where probiotics are used to minimize disease outbreaks and ensure better productivity. The aquaculture sector is also seeing rapid adoption as probiotics help maintain water quality and support fish health. With rising consumer demand for organic and antibiotic-free meat, milk, and fish, probiotics in animal nutrition present a major growth avenue for suppliers. The expansion of this segment not only drives volumes but also strengthens the positioning of probiotics as a sustainable solution in agriculture.
Key Challenges
Regulatory Complexity and Standardization Issues
One of the key challenges in the North America probiotics market is regulatory complexity and lack of standardized guidelines. Probiotics are marketed as foods, supplements, or therapeutic agents, and regulations vary widely across these categories. The U.S. Food and Drug Administration (FDA) requires stringent safety and efficacy data for health claims, which increases approval timelines and costs. Companies often face restrictions in promoting specific health benefits, limiting their marketing potential. Additionally, inconsistency in labeling practices, strain identification, and potency claims creates confusion for consumers and reduces trust. Small and mid-sized firms struggle to navigate these regulatory barriers compared to larger players with established compliance teams. These challenges not only slow down innovation but also restrict market entry for newer companies, impacting competitive growth. Without harmonized standards, achieving wider consumer confidence and consistent global trade for probiotic products remains difficult.
High Costs of Research and Product Development
The development of effective and stable probiotic products requires significant investment in research, strain identification, and clinical validation. Probiotics are sensitive to environmental factors like temperature and pH, making formulation and preservation a technical challenge. Companies must invest in advanced technologies to ensure viability and shelf stability during processing, storage, and distribution. Clinical trials to demonstrate health benefits further increase development costs, which are often prohibitive for smaller companies. These high costs limit innovation and create barriers to entry, concentrating market power among established players. In addition, consumer expectations for affordable yet high-quality probiotic products put pressure on manufacturers to balance costs with competitive pricing. This cost-intensive nature of probiotic development remains a major challenge, particularly as the industry expands into new applications and personalized solutions requiring more specialized formulations.
Regional Analysis
United States
The United States dominated the North America probiotics market in 2024, holding over 75% share. The strong position stems from high consumer awareness of digestive and immune health, coupled with widespread availability of probiotic food, beverages, and supplements. Leading companies focus on expanding dairy-based and plant-based probiotic offerings to meet evolving dietary preferences. Rising adoption of preventive healthcare and functional foods also strengthens demand. Additionally, the large base of retail and online distribution networks ensures broad product reach across urban and rural populations, further solidifying the U.S. as the central growth hub in the regional market.
Canada
Canada accounted for around 15% share of the North America probiotics market in 2024. Growth is driven by rising demand for natural and functional foods, supported by government initiatives promoting gut health awareness. Canadian consumers show strong interest in dairy-based probiotic products, while dietary supplements are also gaining popularity among aging populations. Expanding retail availability of fortified cereals, beverages, and infant nutrition products further supports market expansion. Increased preference for clean-label and organic offerings creates opportunities for manufacturers. The growing influence of health-conscious younger demographics continues to strengthen Canada’s position in the regional probiotics landscape.
Mexico
Mexico represented approximately 10% share of the North America probiotics market in 2024. Demand is rising due to increasing consumer focus on digestive wellness and affordable access to probiotic dairy products such as yogurt and fermented drinks. The market benefits from a strong tradition of fermented foods, which eases acceptance of probiotic-based products. Local and international players are expanding distribution in supermarkets and convenience stores, making probiotics more accessible to a wider consumer base. Growing middle-class populations and rising healthcare costs are driving preventive health practices, supporting steady market growth in Mexico’s probiotics sector.
Market Segmentations:
By Product
Probiotic Food & Beverages
Dairy Products
Cereals
Baked Food
Fermented Meat
Dry Foods
Others
Probiotic Dietary Supplements
Food Supplements
Infant Formula
Others
Animal Feed
By Ingredient
Bacteria
Lactobacillus
Bifidobacterium
Streptococcus
Others
Yeast
Saccharomyces
Others
By End User
Human Probiotics
Adult
Children
Animal Probiotics
Livestock
Poultry
Aquaculture
By Distribution Channel
Hypermarkets/Supermarkets
Pharmacies/Drugstore
Specialty Stores
Online Stores
By Geography
United States
Canada
Mexico
Competitive Landscape
The competitive landscape of the North America probiotics market is characterized by the presence of global leaders and specialized regional players, each focusing on innovation and portfolio expansion. Companies such as ADM, Danone S.A., Nestle S.A., Yakult Honsha Co., Ltd., and Kerry Group dominate through strong product portfolios in probiotic food, beverages, and dietary supplements. Lifeway Foods Inc. strengthens its niche in probiotic dairy, while Lallemand Inc. and Probi emphasize strain development and clinical validation. Firms such as Winclove Probiotics and SYNformulas specialize in targeted formulations, supporting growth in personalized nutrition. International Flavors & Fragrances Inc. (IFF) enhances competitiveness by integrating probiotics with broader health and wellness solutions. Market players invest in R&D, partnerships, and acquisitions to expand applications across human health and animal feed. With consumer demand for functional, clean-label, and personalized products rising, competition is intensifying, compelling companies to prioritize differentiation, regulatory compliance, and product efficacy to maintain market share.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In October 2024, Probi launched clinically-supported probiotic solution for metabolic health.
In August 2024, AB-Biotics launched probiotic solutions Gyntima Menopause (complex probiotic made of Lacotobacillus crispatus KABP™ Lactobacillus plantarum KABP™ 051 (CECT 7481), and Lactococcus lactis KABP™ 021 (CECT 7483). It helps to regulate estrogen level by reactivating it through β-glucuronidase (GUS) activity in women suffering from perimenopausal symptoms.
In August 2024, ZBiotics announced the completion of venture series A (amounting to USD 12 million) in order to support the commercialization of genetically engineered probiotics.
In February 2024, AB Biotics SA (Netherlands) expands its presence in Asia, partnering with Wonderlab for their globally marketed product, AB-LIFE. The collaboration introduces Shape100, a probiotic blend focusing on cardiometabolic health, to the Chinese market. This strategic move aims to address cholesterol-related concerns through evidence-based solutions.
In November 2023, Nestlé (Switzerland) launched N3 milk, a breakthrough in nutritional innovation. Incorporating prebiotic fibers and reduced lactose, it enriches gut health and boasts over 15% fewer calories. Tailored for diverse dietary needs, N3 supports bone health, muscle growth, and immunity.
In April 2022, Symrise, a r producer of cosmetic ingredients, launched SymFerment, a cutting-edge ingredient designed to enhance skin care with its moisturizing and smoothing properties. Developed in collaboration with Probi, a leading manufacturer of probiotics for the healthcare and food industries, SymFerment represents a significant advancement in sustainable cosmetic technology.
Report Coverage
The research report offers an in-depth analysis based on Product,Ingredient, End User, Distribution Channel and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
The market will expand steadily with rising demand for digestive and immune health products.
Probiotic food and beverages will continue to dominate due to strong consumer acceptance.
Dietary supplements will grow faster with increasing adoption among adults and children.
Personalized probiotic solutions will gain traction through microbiome-based product development.
Plant-based probiotic products will see higher demand from vegan and lactose-intolerant consumers.
Probiotics in animal feed will expand with the shift toward antibiotic-free livestock and poultry.
Clinical research will support wider applications in allergy, obesity, and mental health management.
E-commerce platforms will strengthen probiotic accessibility and increase consumer adoption across regions.
Regulatory clarity will improve labeling standards and build stronger consumer trust in products.
The United States will maintain leadership, while Canada and Mexico will witness faster relative growth.
Food Technology Market size was valued USD 209.1 billion in 2024 and is anticipated to reach USD 439.83 billion by 2032, at a CAGR of 9.74% during the forecast period.
Europe Probiotics Market size was valued at USD 10,863.80 million in 2018 and grew to USD 18,798.61 million in 2024. The market is anticipated to reach USD 39,914.09 million by 2032, expanding at a CAGR of 9.8% during the forecast period.
Global Probiotics market size was valued at USD 566.8 million in 2018 and increased to USD 68,971.3 million in 2024. It is anticipated to reach USD 143,112.5 million by 2032, growing at a CAGR of 9.62% during the forecast period.
Japan Probiotics market size was valued at USD 2,482.76 million in 2018 and reached USD 4,319.10 million in 2024. It is anticipated to reach USD 9,236.48 million by 2032, growing at a CAGR of 9.7% during the forecast period.
U.S. Probiotics market size was valued at USD 6,489.64 million in 2018 and grew to USD 10,432.83 million in 2024. It is anticipated to reach USD 20,035.75 million by 2032, at a CAGR of 8.35% during the forecast period.
Australia Probiotics market size was valued at USD 1,511.30 million in 2018 and grew to USD 2,527.53 million in 2024. It is anticipated to reach USD 5,124.14 million by 2032, at a CAGR of 9.3% during the forecast period.
The low sodium sea salt market size was valued at USD 450 million in 2024 and is anticipated to reach USD 690.61 million by 2032, at a CAGR of 5.5 % during the forecast period.
The liquor confectionery market size was valued at USD 741.7 million in 2024 and is anticipated to reach USD 1173.26 million by 2032, at a CAGR of 5.9 % during the forecast period.
The Non-Perishable Milk market was valued at USD 200.47 billion in 2024 and is projected to reach USD 298.45 billion by 2032, expanding at a CAGR of 5.1% during the forecast period.
Hygienic Easy to Clean Food Processing Equipment Market size was valued at USD 53.6 Billion in 2024 and is anticipated to reach USD 79.79 Billion by 2032, at a CAGR of 5.1% during the forecast period.
U.S. Antifreeze Proteins Market size was valued at USD 4.46 million in 2018, reached USD 8.77 million in 2024, and is anticipated to reach USD 51.74 million by 2032, growing at a CAGR of 23.18% during the forecast period.
North America Antifreeze Proteins Market size was valued at USD 5.36 million in 2018, reached USD 10.93 million in 2024, and is anticipated to reach USD 61.69 million by 2032, growing at a CAGR of 22.53% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$3999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
